DK2114441T3 - Anvendelse af alkalisk phosphatase i behandling af nedsat nyrefunktion - Google Patents

Anvendelse af alkalisk phosphatase i behandling af nedsat nyrefunktion

Info

Publication number: DK2114441T3
Authority: DK; Denmark
Prior art keywords: treatment; alkaline phosphatase; renal impairment; impairment; renal
Prior art date: 2007-01-30

Application number

DK08705122.3T

Other languages

English (en)

Inventor

Roelof Peter Pickkers

Suzanne Heemskerk

Markwin Paul Velders

Willem Raaben

Marty Bernardus Fransiscus Wulferink

Original Assignee

Am Pharma Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-01-30

Filing date

2008-01-30

Publication date

2013-01-21

2008-01-30 Application filed by Am Pharma Bv filed Critical Am Pharma Bv

2013-01-21 Application granted granted Critical

2013-01-21 Publication of DK2114441T3 publication Critical patent/DK2114441T3/da

Links

102000002260 Alkaline Phosphatase Human genes 0.000 title 1
108020004774 Alkaline Phosphatase Proteins 0.000 title 1
206010062237 Renal impairment Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03001—Alkaline phosphatase (3.1.3.1)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Urology & Nephrology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Enzymes And Modification Thereof (AREA)

DK08705122.3T 2007-01-30 2008-01-30 Anvendelse af alkalisk phosphatase i behandling af nedsat nyrefunktion DK2114441T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07101437A EP1952823A1 (en)	2007-01-30	2007-01-30	The use of alkaline phosphatase in the treatment of reduced renal function
PCT/NL2008/050053 WO2008094037A1 (en)	2007-01-30	2008-01-30	The use of alkaline phosphatase in the treatment of reduced renal function

Publications (1)

Publication Number	Publication Date
DK2114441T3 true DK2114441T3 (da)	2013-01-21

Family

ID=38002159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08705122.3T DK2114441T3 (da)	2007-01-30	2008-01-30	Anvendelse af alkalisk phosphatase i behandling af nedsat nyrefunktion

Country Status (11)

Country	Link
US (1)	US8586032B2 (da)
EP (2)	EP1952823A1 (da)
JP (2)	JP5580052B2 (da)
CN (3)	CN104189896A (da)
AU (1)	AU2008211829B2 (da)
CA (1)	CA2676968C (da)
DK (1)	DK2114441T3 (da)
ES (1)	ES2397293T3 (da)
HK (2)	HK1204925A1 (da)
PL (1)	PL2114441T3 (da)
WO (1)	WO2008094037A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2005210581B2 (en)	2004-02-04	2010-06-24	Am-Pharma B.V.	Use of alkaline phosphatase for the detoxification of LPS present at mucosal barriers
US20110142817A1 (en) *	2004-02-04	2011-06-16	Pharmaaware Sepsis B.V.	Means and method for treating and/or preventing necrotizing enterocolitis
EP1952823A1 (en)	2007-01-30	2008-08-06	AM-Pharma B.V.	The use of alkaline phosphatase in the treatment of reduced renal function
EP1985697A1 (en) *	2007-04-27	2008-10-29	AM-Pharma B.V.	Modified phosphatases
CA2732438A1 (en)	2008-08-29	2010-03-04	The General Hospital Corporation	Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
CA2735590A1 (en) *	2008-08-29	2010-03-04	Astute Medical, Inc.	Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011100543A2 (en)	2010-02-12	2011-08-18	The General Hospital Corporation	Methods of reducing or inhibiting toxic effects associated with a bacterial infection using alkaline phosphatase
BR112013015392A2 (pt)	2010-12-20	2016-09-20	Koninkl Philips Electronics Nv	dispositivo de interface de paciente e método de prender um dispositivo de interface de paciente à cabeça de um paciente
DK2717906T5 (da) *	2011-06-08	2017-06-19	Am-Pharma B V	Anvendelse af alkalisk phosphatase til bevaring af nyrefunktion
WO2015112017A1 (en)	2014-01-24	2015-07-30	Am-Pharma B.V.	Chimeric alkaline phosphatase-like proteins
DK3461891T3 (da) *	2014-01-24	2020-08-10	Am-Pharma Bv	Nedstrømsbehandling af en alkalisk phosphatase
WO2018175413A1 (en)	2017-03-21	2018-09-27	Synthetic Biologics, Inc.	Alkaline phosphatase formulations
AU2019207600B2 (en)	2018-01-09	2025-01-09	Theriva Biologics, Inc.	Alkaline phosphatase agents for treatment of neurodevelopmental disorders
DK3762018T3 (da)	2018-03-08	2024-05-06	Am Pharma Bv	Rekombinant alkalisk phosphatase til anvendelse i behandling af sepsis-forbundet akut nyrelæsion
EP4275761A3 (en)	2018-03-20	2024-02-28	Theriva Biologics, Inc.	Alkaline phosphatase agents for treatment of radiation disorders
EP3768302B1 (en)	2018-03-20	2025-05-07	Theriva Biologics, Inc.	Intestinal alkaline phosphatase formulations
WO2020227263A1 (en)	2019-05-06	2020-11-12	Synthetic Biologics, Inc.	Alkaline phosphate-based oncology treatments
EP3975999A4 (en)	2019-06-03	2023-07-19	Theriva Biologics, Inc.	ALKALINE PHOSPHATASE FORMULATIONS AND THEIR USES
CN112760305B (zh) *	2021-01-25	2022-04-29	浙江工业大学	一种栖热腔菌磷酸酶突变体及其应用
CN115990245B (zh) *	2022-07-15	2025-04-01	中山大学附属第一医院	一种含肠型碱性磷酸酶的抗腹膜纤维化透析液的制备方法
CN121038803A (zh) *	2023-03-21	2025-11-28	安-法玛公司	用于治疗慢加急性肾损伤的碱性磷酸酶

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU690941B2 (en) *	1993-11-15	1998-05-07	Celtrix Pharmaceuticals, Inc.	Method of treating renal disease by administering IGF-I and IGFBP-3
ATE327751T1 (de) *	2000-01-31	2006-06-15	Pfizer Prod Inc	Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz
CN1425766A (zh)	2001-12-19	2003-06-25	复旦大学	一种多肽——人含碱性磷酸酶活性位点的蛋白－9.24和编码这种多肽的多核苷酸
US7048914B2 (en) *	2002-12-12	2006-05-23	Zoltan Laboratories	Placental alkaline phosphatase to control diabetes
AU2005210581B2 (en) *	2004-02-04	2010-06-24	Am-Pharma B.V.	Use of alkaline phosphatase for the detoxification of LPS present at mucosal barriers
EP1952823A1 (en)	2007-01-30	2008-08-06	AM-Pharma B.V.	The use of alkaline phosphatase in the treatment of reduced renal function

2007
- 2007-01-30 EP EP07101437A patent/EP1952823A1/en not_active Withdrawn
2008
- 2008-01-30 JP JP2009548182A patent/JP5580052B2/ja active Active
- 2008-01-30 CN CN201410332389.XA patent/CN104189896A/zh active Pending
- 2008-01-30 EP EP08705122A patent/EP2114441B1/en active Active
- 2008-01-30 CN CN200880003595A patent/CN101678085A/zh active Pending
- 2008-01-30 CA CA2676968A patent/CA2676968C/en active Active
- 2008-01-30 US US12/449,192 patent/US8586032B2/en active Active
- 2008-01-30 WO PCT/NL2008/050053 patent/WO2008094037A1/en not_active Ceased
- 2008-01-30 PL PL08705122T patent/PL2114441T3/pl unknown
- 2008-01-30 CN CN201610862195.XA patent/CN106466476A/zh active Pending
- 2008-01-30 DK DK08705122.3T patent/DK2114441T3/da active
- 2008-01-30 ES ES08705122T patent/ES2397293T3/es active Active
- 2008-01-30 AU AU2008211829A patent/AU2008211829B2/en active Active
2014
- 2014-03-05 JP JP2014043349A patent/JP5734482B2/ja active Active
2015
- 2015-06-09 HK HK15105481.8A patent/HK1204925A1/xx unknown
2017
- 2017-06-16 HK HK17105996.4A patent/HK1232161A1/zh unknown

Also Published As

Publication number	Publication date
PL2114441T3 (pl)	2013-03-29
EP2114441A1 (en)	2009-11-11
CN101678085A (zh)	2010-03-24
CN104189896A (zh)	2014-12-10
JP5580052B2 (ja)	2014-08-27
CN106466476A (zh)	2017-03-01
JP2014139202A (ja)	2014-07-31
JP5734482B2 (ja)	2015-06-17
ES2397293T3 (es)	2013-03-06
EP2114441B1 (en)	2012-10-17
CA2676968A1 (en)	2008-08-07
US20100111923A1 (en)	2010-05-06
AU2008211829A1 (en)	2008-08-07
HK1232161A1 (zh)	2018-01-05
CA2676968C (en)	2015-06-16
WO2008094037A1 (en)	2008-08-07
EP1952823A1 (en)	2008-08-06
JP2010516808A (ja)	2010-05-20
AU2008211829B2 (en)	2012-09-13
HK1204925A1 (en)	2015-12-11
US8586032B2 (en)	2013-11-19

Publication	Publication Date	Title
PL2114441T3 (pl)	2013-03-29	Zastosowanie fosfatazy alkalicznej w zmniejszonej funkcji nerek
EP2049713A4 (en)	2010-06-16	tissue rejection
DE602008005653D1 (de)	2011-05-05	Femurtrochlea-Prothese
IL246421A0 (en)	2016-08-31	Self-expanding devices
BRPI0812536A2 (pt)	2015-02-10	Prótese de núcleo
DK2166887T3 (da)	2012-02-20	Filter
BRPI0808044A2 (pt)	2017-05-09	sistemas e métodos de hemodiálise
DK2124829T3 (da)	2014-04-22	Omvendt skulderprotese
DE602008002748D1 (de)	2010-11-04	Linseneinführsystem
DE602008000004D1 (de)	2009-05-20	Linseneinführsystem
EP2121110A4 (en)	2012-08-08	BIOKOMPATIBLE WUNDAUFLAGE
BRPI0814860A2 (pt)	2015-02-03	Elementos de filtro
PL2124831T3 (pl)	2017-03-31	Urządzenia protetyczne
BRPI0815527A2 (pt)	2015-02-03	"filtro"
BRPI0819073A2 (pt)	2018-10-23	fralda descartável
DK2175851T3 (da)	2013-07-15	Biofilmbehandling
DK2200600T3 (da)	2012-01-23	Neramexan til anvendelse ved behandlingen af subakut tinnitus
BRPI0811008A2 (pt)	2015-01-27	Conjunto de filtro
DE602008006709D1 (de)	2011-06-16	Funduskamera
BRPI0819071A2 (pt)	2018-10-23	fralda descartável
BRPI0815815A2 (pt)	2015-02-18	Obturador de múltiplos estágios
KR100788052B9 (ko)	2022-10-04	샤워 필터 장치
DK2190386T3 (da)	2011-07-11	Endoprotesekomponent
EP2191071A4 (en)	2013-11-13	ARTIFICIAL STONE PLATE
DK2001499T3 (da)	2013-09-08	Anvendelse af TGS-6 til behandling af osteoporose